Novo Nordisk A/S

OTC: NONOF · Real-Time Price · USD
52.37
2.11 (4.20%)
At close: Aug 15, 2025, 3:44 PM
51.00
-2.61%
Pre-market: Aug 15, 2025, 11:51 AM EDT

Novo Nordisk A/S Balance Sheet Statement

Financials in DKK. Fiscal year is undefined.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
38.94B 15.65B 57.02B 52.82B 6.32B 14.39B 30.14B 21.57B 14.94B 12.65B 28.46B 22.76B 13.39B 10.72B 29.49B 24.23B 5.68B
Short-Term Investments
2.61B 10.65B 17.86B 9.83B 2.98B 15.84B 17.45B 14.83B 12.84B 10.92B 9.01B 8.28B 6.75B 6.76B 5.9B 2.99B 1.98B
Long-Term Investments
2.7B 2.68B 2.05B 1.66B 1.65B 1.66B 1.47B 1.48B 1.21B 1.34B 1.24B 1.24B 1.28B 1.44B 1.78B 1.84B 1.75B
Other Long-Term Assets
4.04B 4.02B 2.46B 2.18B 2.01B 1.43B 430M 338M 288M 206M 247M 252M 239M 267M 332M 413M 551M
Receivables
86.37B 87.41B 69.5B 63.56B 57B 64.77B 61.96B 70.52B 57.92B 57.51B 45.56B 46.64B 36.24B 46.8B 35.45B 30.22B 28.03B
Inventory
42.85B 40.85B 37.94B 36.36B 33.6B 31.81B 29.53B 28.02B 25.61B 24.39B 23.22B 21.71B 20.29B 19.62B 18.9B 18.82B 18.65B
Other Current Assets
3.63B 6.33B 2.71B 14.93B 16.52B 12.84B 12.47B 11.83B 10.05B 9.67B 13.22B 9.41B 9.86B 7.85B 7.06B 5.01B 7.04B
Total Current Assets
174.4B 160.9B 195.16B 177.5B 116.42B 139.65B 142.2B 137.55B 113.94B 108.19B 119.48B 102.98B 86.54B 85.59B 91.21B 77.15B 61.39B
Property-Plant & Equipment
172.38B 162.49B 119.83B 109.98B 98.23B 90.96B 81.46B 75.02B 70.01B 66.67B 63.64B 59.56B 56.4B 55.36B 52.86B 52.08B 51.43B
Goodwill & Intangibles
109.38B 111.09B 54.49B 55.5B 59.64B 60.41B 55.73B 50.75B 50.49B 51.42B 46.92B 44.59B 43.34B 43.17B 20.53B 20.27B 20.36B
Total Long-Term Assets
314.77B 304.9B 202.28B 191.88B 182.5B 174.84B 157.9B 143.2B 136.08B 133.06B 123.35B 115.95B 110.6B 108.91B 82.87B 80.95B 80B
Total Assets
489.16B 465.8B 397.44B 369.38B 298.92B 314.49B 300.1B 280.75B 250.03B 241.26B 242.84B 218.93B 197.14B 194.51B 174.08B 158.09B 141.39B
Account Payables
19.58B 28.85B 24.08B 29.76B 13.01B 25.61B 20.11B 17.79B 10.05B 15.59B 8.31B 14.65B 6.68B 8.87B 8.88B 7.62B 6.8B
Deferred Revenue
n/a n/a n/a 5.91B 5.96B 107.59B 117.14B 108.47B n/a n/a n/a n/a n/a 55.18B 58.86B 49.29B 41.42B
Short-Term Debt
22.41B 11.78B 5.52B 5.45B 10.16B 5.3B 6.61B 6.29B 1.25B 480M 1.83B 1.26B 1.4B 12.86B 1.35B 1.3B 6.82B
Other Current Liabilities
178.63B 165.85B 164.11B 146.79B 136.47B 38.14B 28.69B 24.07B 120.66B 103.89B 120.11B 93.75B 87.53B 21.78B 19.24B 14.59B 17.34B
Total Current Liabilities
236.12B 217.53B 208.36B 187.91B 165.61B 169.66B 172.55B 156.62B 131.96B 120.94B 130.26B 109.66B 95.6B 99.52B 88.33B 72.8B 72.38B
Long-Term Debt
96.31B 84.25B 51.45B 51.61B 16.76B 15.98B 19.92B 19.41B 24.27B 20.77B 24.14B 24.18B 24.08B 9.65B 12.4B 12.46B 2.83B
Other Long-Term Liabilities
9.49B 9.68B 8.45B 8.31B 7.98B 189M 199M 193M 6.05B 5.45B 6.12B 5.43B 5.59B 360M 5.6B 5.46B 2.88B
Total Long-Term Liabilities
114.5B 104.78B 68.56B 68.95B 34.4B 38.27B 34.56B 33.66B 38.19B 36.83B 35.9B 34.82B 34.98B 24.25B 19.64B 19.74B 10.51B
Total Liabilities
350.62B 322.31B 276.92B 256.86B 200.01B 207.93B 207.11B 190.28B 170.15B 157.77B 166.16B 144.48B 130.59B 123.76B 107.97B 92.54B 82.89B
Total Debt
118.72B 102.79B 56.97B 57.06B 26.93B 27.01B 26.54B 25.7B 25.52B 25.78B 25.97B 25.43B 25.48B 26.64B 13.75B 13.76B 9.65B
Common Stock
446M 446M 446M 446M 451M 451M 451M 451M 456M 456M 456M 456M 462M 462M 462M 462M 470M
Retained Earnings
137.32B 144.45B 121.67B 112.15B 99.05B 104.84B 91.73B 88.12B 77.07B 80.59B 73.67B 73.17B 66.61B 72B 67.91B 67.18B 60.3B
Comprehensive Income
777M -1.41B n/a -73M -585M 1.28B 810M 1.91B 2.35B 2.45B 2.56B 833M -517M -1.71B -2.26B -2.08B -2.26B
Shareholders Equity
138.54B 143.49B 120.52B 112.52B 98.91B 106.56B 92.99B 90.47B 79.87B 83.49B 76.68B 74.45B 66.55B 70.75B 66.11B 65.56B 58.5B
Total Investments
5.31B 13.33B 19.91B 11.49B 4.63B 17.5B 18.92B 16.31B 14.05B 12.26B 10.25B 9.52B 8.03B 8.21B 7.67B 4.83B 3.73B